Daniel Aughenbaugh's Contact Details

Daniel Aughenbaugh's Company Details

CordenPharma

Boulder, CO, US • 1000 - 4999 Employees
Major Drugs

CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under five technology platforms – Peptides - Lipids & Carbohydrates – Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products. << Peptides >>• Synthetic Peptide API Production - Solid-phase, Liquid-phase, Hybrid Synthesis - cGMP & non-cGMP<< Lipids & Carbohydrates >>• Standard and Custom Lipids (Cationic lipids, PEG-lipids, cholesterol (plant-based), phospholipids, Lipids package solution for LNP, liposome formulation)• Carbohydrates(Carbohydrates (i.e. GalNac) for peptides, oligonucleotide drug delivery & formulation)<< Sterile Injectables >>• New Development & Commercial Suites for Aseptic Filling with > 60.000 units per day (Pre-filled Syringes, Liquid or Lyophilized Vials)• Packaging, Labeling & Logistics• Sterile Emulsion Technology• Large Pre-Filled Syringes• Clinical Trial Services<< Highly Potent & Oncology >>• API Development & Commercial Manufacturing (SafeBridge Category 4, OEL ≤1 ng/m3) - New Development & Scale-up Capacity for Phase I/II Supply• Drug Product Development & Manufacturing - New Development Suite (CTD2) for Mid-scale Oral Dosage (up to 20 kg) - Sterile Liquid & Lyophilization - Primary & Secondary Packaging << Small Molecules >>• Development & Commercial Manufacturing - Intermediates - APIs & Excipients - Clinical Supply Phases I-III• Proprietary & Generic Advanced Intermediates & APIs Visit > www.cordenpharma.com